为了加强领导力,Telix任命两位新的独立董事. Telix appoints two new independent directors to its board to strengthen leadership.

德力克斯制药公司宣布任命两位新的独立董事,加强企业治理和监督. Telix Pharmaceuticals announced the appointment of two new independent directors to its board, enhancing corporate governance and oversight. 这些新任职员在生命科学和投资领域拥有丰富的经验. The new appointees bring extensive experience in the life sciences and investment sectors. 这一举动标志着公司加强领导团队的战略, 随着其药品组合的发展. This move signals the company's strategy to strengthen its leadership team as it advances its pharmaceutical portfolio.